Deutsche Bank Ag\ Tenaya Therapeutics, Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Tenaya Therapeutics, Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 32,001 shares of TNYA stock, worth $45,761. This represents 0.0% of its overall portfolio holdings.

Number of Shares

32,001

Previous 23,214 37.85%

Holding current value

$45,761

Previous $71,000 14.08%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.93 - $3.99 $16,958 - $35,060	8,787 Added 37.85%	32,001 $61,000
Q2 2024 Aug 14, 2024	SELL	$2.72 - $4.99 $9,242 - $16,956	-3,398 Reduced 12.77%	23,214 $71,000
Q1 2024 May 15, 2024	BUY	$2.88 - $6.8 $59,011 - $139,332	20,490 Added 334.69%	26,612 $139,000
Q4 2023 Feb 14, 2024	SELL	$1.73 - $3.39 $40,139 - $78,654	-23,202 Reduced 79.12%	6,122 $19,000
Q3 2023 Nov 09, 2023	SELL	$2.55 - $5.65 $17,944 - $39,759	-7,037 Reduced 19.35%	29,324 $74,000
Q2 2023 Aug 14, 2023	BUY	$2.64 - $7.64 $586 - $1,696	222 Added 0.61%	36,361 $213,000
Q1 2023 May 15, 2023	BUY	$1.92 - $3.59 $45,523 - $85,118	23,710 Added 190.76%	36,139 $102,000
Q4 2022 Feb 13, 2023	BUY	$1.68 - $3.19 $315 - $599	188 Added 1.54%	12,429 $24,000
Q3 2022 Nov 14, 2022	SELL	$2.9 - $5.88 $5,417 - $10,983	-1,868 Reduced 13.24%	12,241 $35,000
Q2 2022 Aug 11, 2022	SELL	$5.01 - $14.12 $13,887 - $39,140	-2,772 Reduced 16.42%	14,109 $79,000
Q1 2022 May 13, 2022	BUY	$9.41 - $19.3 $79,185 - $162,409	8,415 Added 99.4%	16,881 $199,000
Q4 2021 Feb 11, 2022	BUY	$18.41 - $29.58 $8,284 - $13,311	450 Added 5.61%	8,466 $160,000
Q3 2021 Nov 04, 2021	BUY	$15.35 - $26.66 $123,045 - $213,706	8,016 New	8,016 $166,000

Others Institutions Holding TNYA

# of Institutions

Shares Held

56.3M

Call Options Held

900

Put Options Held

400

View Full List

About Tenaya Therapeutics, Inc.

Ticker TNYA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,364,700
Market Cap $59.2M
Description
Tenaya Therapeutics, Inc., a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno-associated virus (AAV)-based gene therapy to address genetic hyp...

More about TNYA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account